Study Finds Higher Drug Co-Pays Discourage Patients From Starting Treatment, RAND Corporation

EurekAlert -- Patients newly diagnosed with hypertension, diabetes or high cholesterol are significantly more likely to delay initiating recommended drug treatment if they face higher co-payments for medications, according to a new RAND Corporation study.